These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21586883)

  • 21. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate may not increase risk of urolithiasis: A nationwide population-based cohort study.
    Shen AL; Lin HL; Tseng YF; Lin HC; Hsu CY; Chou CY
    Seizure; 2015 Jul; 29():86-9. PubMed ID: 26076848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of topiramate in children younger than 2 years old.
    Valencia I; Fons C; Kothare SV; Khurana DS; Yum S; Hardison HH; Legido A
    J Child Neurol; 2005 Aug; 20(8):667-9. PubMed ID: 16225812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topiramate in children with west syndrome: a retrospective multicenter evaluation of 100 patients.
    Korinthenberg R; Schreiner A
    J Child Neurol; 2007 Mar; 22(3):302-6. PubMed ID: 17621500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate for drug-resistant epilepsies.
    Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
    Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible hemiparesis associated with the use of topiramate.
    Patel H; Asconapé JJ; Garg BP
    Seizure; 2002 Oct; 11(7):460-3. PubMed ID: 12237075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. West syndrome, can topiramate be on top?
    Al-Baradie RS; Elseed MA
    Neurosciences (Riyadh); 2011 Jan; 16(1):53-6. PubMed ID: 21206445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients.
    Thijs J; Verhelst H; Van Coster R
    Acta Neurol Belg; 2001 Sep; 101(3):171-6. PubMed ID: 11817266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predisposition to metabolic acidosis induced by topiramate.
    Montenegro MA; Guerreiro MM; Scotoni AE; Guerreiro CA
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1021-4. PubMed ID: 11105067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Staghorn calculus secondary to topiramate].
    López-Real AM; García-Antelo MJ; Fernández-Couto D; López-Facal S; Rubio-Nazabal E
    Farm Hosp; 2008; 32(5):299-300. PubMed ID: 19150048
    [No Abstract]   [Full Text] [Related]  

  • 31. [Urolithiasis induced by combined ACTH and zonisamide treatment in a patient with startle induced epilepsy].
    Saito Y; Yanagaki S; Oguni H; Hayashi K; Katsumori H; Nagafuchi H; Jo K; Osawa M
    No To Hattatsu; 2002 Sep; 34(5):415-20. PubMed ID: 12233054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: prevalence and spot urine risk factors for renal stones in children taking topiramate.
    Eva Fung LW; Ng CF
    J Pediatr Urol; 2014 Jun; 10(3):582. PubMed ID: 24529689
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased propensity for calcium phosphate kidney stones with topiramate use.
    Vega D; Maalouf NM; Sakhaee K
    Expert Opin Drug Saf; 2007 Sep; 6(5):547-57. PubMed ID: 17877442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate associated hypohidrosis and hyperthermia.
    Incecik F; Hergüner MO; Altunbasak S
    Indian Pediatr; 2008 Mar; 45(3):238-40. PubMed ID: 18367774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topiramate and metabolic acidosis: a case series and review of the literature.
    Groeper K; McCann ME
    Paediatr Anaesth; 2005 Feb; 15(2):167-70. PubMed ID: 15675937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperventilation and cerebrospinal fluid acidosis caused by topiramate.
    Montcriol A; Meaudre E; Kenane N; Asencio Y; Bordes J; Palmier B
    Ann Pharmacother; 2008 Apr; 42(4):584-7. PubMed ID: 18420530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension.
    Jion YI; Raff A; Grosberg BM; Evans RW
    Headache; 2015 Jan; 55(1):161-6. PubMed ID: 25486999
    [No Abstract]   [Full Text] [Related]  

  • 39. Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate.
    Kaplon DM; Penniston KL; Nakada SY
    Urology; 2011 Feb; 77(2):295-8. PubMed ID: 20888032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial.
    Al Ajlouni S; Shorman A; Daoud AS
    Seizure; 2005 Oct; 14(7):459-63. PubMed ID: 16087357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.